Hiponatremia

01Pathophysiology

Sodium is the primary determinant of serum osmolality and therefore the principal regulator of water distribution between the intracellular and extracellular compartments. The serum osmolality can be estimated using:

$$SerumOsmolality\approx 2[N{a}^{+}]+\frac{Glucose}{18}+\frac{BUN}{2.8}Serum\backslash \; Osmolality\; \backslash approx\; 2[Na^+]\; +\; \backslash frac\{Glucose\}\{18\}\; +\; \backslash frac\{BUN\}\{2.8\}$$

When serum sodium falls, the extracellular fluid becomes hypotonic relative to the intracellular compartment. Water moves down its osmotic gradient into cells, causing cellular swelling. In the brain, this swelling is particularly dangerous because the rigid skull limits expansion. Cerebral edema is the direct cause of the neurological symptoms seen in hyponatremia, ranging from headache and confusion to seizures, herniation, and death.

The body defends against hyponatremia primarily through ADH (antidiuretic hormone / vasopressin). Under normal physiology, falling osmolality suppresses ADH release, allowing free water excretion. Hyponatremia develops when this defense fails, either because ADH is inappropriately elevated (SIADH), the kidneys cannot excrete free water (renal failure, very low solute intake), or the stimulus for ADH is non-osmotic (hypovolemia, pain, nausea, medications).

A critical concept the test-writer expects you to understand: the rate of onset determines the severity of symptoms, not just the absolute sodium level. Acute hyponatremia (developing in < 48 hours) is more dangerous because brain cells have not had time to adapt by extruding intracellular osmoles. Chronic hyponatremia (> 48 hours) may be surprisingly well-tolerated even at very low sodium levels because the brain has adapted. This adaptation, however, creates a new danger during correction: if you raise sodium too quickly in a chronically adapted brain, you cause osmotic demyelination syndrome (ODS), formerly called central pontine myelinolysis.

Before classifying the cause, you must first rule out pseudohyponatremia and hypertonic hyponatremia. Pseudohyponatremia occurs with extreme hyperlipidemia or hyperproteinemia, where the lab artifact falsely lowers the measured sodium (serum osmolality will be normal). Hypertonic hyponatremia occurs when an osmotically active solute like glucose draws water into the extracellular space, diluting sodium. For every 100 mg/dL increase in glucose above normal, sodium falls by approximately 1.6 to 2.4 mEq/L. In both cases, the serum osmolality is NOT low, so they are not true hypotonic hyponatremia.

02Classification and Clinical Manifestation

The classification of hyponatremia is built around two axes: volume status and urine studies. This is the framework the test-writer uses to build answer choices.

Classification by Volume Status

Classification by Severity and Symptoms

Classification by Chronicity

03Diagnostic Workup

The diagnostic algorithm is the most tested aspect of hyponatremia. The test-writer will give you a sodium value and expect you to follow a stepwise approach:

Step 1: Confirm it is real. Check serum osmolality. If osmolality is normal (280 to 295), consider pseudohyponatremia. If osmolality is elevated (> 295), think about hyperglycemia or mannitol infusion. Only proceed if osmolality is low (< 280), confirming true hypotonic hyponatremia.

Step 2: Assess volume status clinically. This is where the vignette gives you physical exam clues. Edema, ascites, and JVD point to hypervolemic. Dry mucosa, tachycardia, and orthostatic hypotension point to hypovolemic. A clinically normal exam points to euvolemic.

Step 3: Check urine osmolality. If urine osmolality is < 100 mOsm/kg, ADH is appropriately suppressed, and the problem is excessive free water intake (psychogenic polydipsia) or very low solute intake (beer potomania, tea-and-toast diet). If urine osmolality is > 100, ADH is active, and you move to Step 4.

Step 4: Check urine sodium. This separates causes within each volume category. In hypovolemic patients, urine Na < 20 points to extrarenal losses (GI losses, skin losses), while urine Na > 20 points to renal losses (thiazides, adrenal insufficiency, cerebral salt wasting). In euvolemic patients, urine Na > 40 with urine osmolality > 100 strongly supports SIADH.

SIADH deserves special emphasis because it is the most commonly tested cause of euvolemic hyponatremia. The diagnosis requires: hyponatremia with low serum osmolality, urine osmolality > 100 mOsm/kg, urine sodium > 40 mEq/L, clinical euvolemia, normal thyroid and adrenal function, no diuretic use. Common causes include CNS disorders (stroke, hemorrhage, trauma), pulmonary disease (pneumonia, especially Legionella; small cell lung cancer), medications (SSRIs, carbamazepine, cyclophosphamide, vincristine, NSAIDs), and pain/nausea as non-osmotic ADH stimuli.

04Management and Treatment

Acute stabilization of severe hyponatremia takes priority over diagnosing the cause. If a patient presents with seizures or altered consciousness, the immediate next step is 3% hypertonic saline, regardless of the underlying etiology. You do not need a urine sodium or TSH before treating a seizing patient.

For chronic hyponatremia, the critical management principle is the rate of correction. The widely accepted safe limit is no more than 8 mEq/L in any 24-hour period (some guidelines use 10 to 12 mEq/L, but exam questions almost always test the more conservative 8 mEq/L threshold). Exceeding this rate in a chronically adapted brain causes osmotic demyelination syndrome, which presents days after correction with dysarthria, dysphagia, quadriparesis, "locked-in syndrome," and characteristic pontine lesions on MRI.

There are populations at higher risk for ODS who warrant even more cautious correction (target 4 to 6 mEq/L per 24 hours): patients with chronic alcoholism, malnutrition, hypokalemia, liver disease, and those with sodium < 105 mEq/L.

An important management pearl: when treating hypovolemic hyponatremia with normal saline, the sodium may rise dangerously fast once volume is restored. This happens because ADH was being driven by hypovolemia; once volume is repleted, ADH shuts off abruptly and the kidneys dump large volumes of dilute urine. This is called autocorrection, and it is a common clinical scenario where overcorrection occurs. Preemptive DDAVP can be administered as a safety clamp in high-risk patients.

For hypokalemia coexisting with hyponatremia: potassium repletion raises serum sodium because potassium is an intracellular cation that exchanges with sodium. You must account for potassium given when calculating total correction rate.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The single most common way students lose points on hyponatremia questions is failing to follow the diagnostic algorithm in order. The test-writer builds vignettes that punish you for jumping to a diagnosis without first checking serum osmolality. A patient with hyperglycemia and low sodium does NOT have true hyponatremia, and treating it as such is a classic wrong answer. Always confirm hypotonic hyponatremia before classifying by volume status.

The second major trap is confusing SIADH with cerebral salt wasting after a neurosurgical or SAH scenario. The vignette will include subtle volume status clues (high urine output and orthostatic vital signs for CSW vs. normal volume exam for SIADH). Choosing the wrong one leads you to the opposite treatment: saline for CSW, fluid restriction for SIADH.

The third trap involves overcorrection. The test-writer loves to present a patient whose sodium corrects too quickly after normal saline infusion for hypovolemic hyponatremia. The expected answer is DDAVP plus D5W to deliberately re-lower the sodium. Students who do not know about the overcorrection rescue protocol will choose to simply "monitor," which is incorrect.

A frequently missed pearl: thiazide diuretics cause hyponatremia, but loop diuretics generally do not (or do so far less commonly). Thiazides impair the diluting segment in the distal tubule without interfering with the medullary concentrating gradient, so ADH can still concentrate urine. Loop diuretics wash out the medullary gradient, impairing both concentration and dilution, which paradoxically protects against severe hyponatremia.

Finally, remember that potassium correction counts toward sodium correction. If you give KCl to a hyponatremic, hypokalemic patient, the potassium enters cells and sodium exits, raising the serum sodium. If a patient receives both hypertonic saline and aggressive potassium repletion simultaneously, the combined effect can push correction beyond the safe threshold. The test-writer expects you to account for this.